{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/lyme-disease/diagnosis/when-to-suspect-lyme-disease/","result":{"pageContext":{"chapter":{"id":"0cf6a4b7-b848-5424-b311-ae2e70bf1cf4","slug":"when-to-suspect-lyme-disease","fullItemName":"When to suspect Lyme disease","depth":2,"htmlHeader":"<!-- begin field 8a2a5248-6d7e-4635-9f4b-9fb40da1a4f3 --><h2>When should I suspect a diagnosis of Lyme disease?</h2><!-- end field 8a2a5248-6d7e-4635-9f4b-9fb40da1a4f3 -->","summary":"","htmlStringContent":"<!-- begin item 59080da2-680b-465b-9464-15b758698148 --><!-- begin field efc224ed-2dfb-466d-b6ae-204da4089463 --><ul><li><strong>Make a clinical diagnosis of Lyme disease </strong>in people with <a class=\"topic-reference internal-reference\" href=\"/topics/lyme-disease/diagnosis/when-to-suspect-lyme-disease/#erythema-migrans\">erythema migrans</a>. </li><li><strong>For people <em>without</em> erythema migrans, clinical presentation and laboratory testing is used to guide diagnosis and treatment. </strong></li><li><strong>Consider</strong> the possibility of Lyme disease in people presenting with several of the following symptoms, because Lyme disease is a possible (but uncommon) cause of:<ul><li>Cognitive impairment, such as memory problems and difficulty concentrating.</li><li>Fatigue.</li><li>Fever and sweats. </li><li>Headache.</li><li>Malaise.</li><li>Migratory joint or muscle aches and pain.</li><li>Neck pain or stiffness.</li><li>Paraesthesia.</li><li>Swollen glands.</li></ul></li><li><strong>Consider </strong>the possibility of Lyme disease in people presenting with symptoms and signs relating to one or more organ systems (focal symptoms), because Lyme disease is a possible (but uncommon) cause of:<ul><li>Eye symptoms — such as uveitis or keratitis.</li><li>Inflammatory arthritis affecting one or more joints that may be fluctuating and migratory cardiac problems — such as heart block or pericarditis.</li><li>Neurological symptoms — such as facial palsy or other unexplained cranial nerve palsies, meningitis, mononeuritis multiplex or other unexplained radiculopathy; or rarely encephalitis, neuropsychiatric presentations or unexplained white matter changes on brain imaging.</li><li>Skin rashes — such as acrodermatitis chronica atrophicans or lymphocytoma.</li></ul></li><li><strong>If the person may have been bitten by a tick whilst abroad, </strong>consider the possibility of <a class=\"topic-reference internal-reference\" href=\"/topics/lyme-disease/background-information/other-tick-borne-diseases/\">other tick-borne diseases</a> (or possible co-infection), particularly if the person has symptoms atypical of Lyme disease.</li><li>If symptoms suggest the possibility of Lyme disease, ask:<ul><li>How long the person has had symptoms. </li><li>About their history of possible tick exposure — for example, activities that might have exposed them to ticks, such as travel to areas where Lyme disease is known to be highly prevalent.</li></ul></li><li><strong>Do not: </strong><ul><li>Rule out the possibility of Lyme disease in people with symptoms but no clear history of tick exposure.</li><li>Diagnose Lyme disease in people without symptoms, even if they have had a tick bite.</li></ul></li></ul><!-- end field efc224ed-2dfb-466d-b6ae-204da4089463 --><!-- end item 59080da2-680b-465b-9464-15b758698148 -->","topic":{"id":"56ba86e1-b79d-5c00-948b-65c581b69f79","topicId":"7aa291ec-f53e-44b9-8a66-e9b4ee6a577f","topicName":"Lyme disease","slug":"lyme-disease","lastRevised":"Last revised in August 2019","chapters":[{"id":"5995c194-77ea-5203-83e7-86b64985db74","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"cc168196-a2da-5a8f-873c-fb75c4c3960f","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"a8622b23-7f1f-543b-b5ba-e9f4c9547c1c","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"4c25a599-a26d-5702-b9f6-43dff73c83c8","slug":"changes","fullItemName":"Changes"},{"id":"29379f04-710e-5ce7-ba07-ea9a1e178ac7","slug":"update","fullItemName":"Update"}]},{"id":"bc55cfd2-4253-598a-8be1-54061ce22b6a","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"49a7229f-6129-58a8-9b6e-7471ccde1b15","slug":"goals","fullItemName":"Goals"},{"id":"ca83767e-8bdd-5ab2-b78a-c8577ab6da08","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"928ab402-0b5e-53b7-96d3-a64275903911","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"d5230b0a-b405-5725-9a8a-95f4a63239e1","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a9b48f27-60ba-54c9-9deb-e1ce41732fc9","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"5cc0f690-6775-5131-a1fc-75d9efa0b535","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"8bbfecb1-6cb7-511b-9697-7915788a4bff","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"1c94f9ce-3656-59d3-86ed-d515d113270a","slug":"definition","fullItemName":"Definition"},{"id":"1a4679d0-b6d3-5b97-917c-5d08de1be33b","slug":"causes","fullItemName":"Causes"},{"id":"6e585a22-8dfe-578a-99a9-1be143896b7f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"e1ded21e-6325-5c18-ae0a-6b540cd28c19","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"126215ba-45c3-5bbf-ae98-2fff7bb1ed89","slug":"prognosis","fullItemName":"Prognosis"},{"id":"5240144c-4a60-5d30-ab1e-63d4f2995a2f","slug":"complications","fullItemName":"Complications"},{"id":"a5092448-11ae-5b17-8a6b-8b6f6d5b80cf","slug":"other-tick-borne-diseases","fullItemName":"Other tick-borne diseases"}]},{"id":"d2ae2f81-2546-5ff8-8002-577ff4741f57","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"0cf6a4b7-b848-5424-b311-ae2e70bf1cf4","slug":"when-to-suspect-lyme-disease","fullItemName":"When to suspect Lyme disease"},{"id":"868a26b1-1742-50d5-8576-14ab327a0c64","slug":"differential-diagnosis-erythema-migrans","fullItemName":"Differential diagnosis (erythema migrans)"}]},{"id":"1a2edd0e-8cc2-5cce-aa6f-5519b5f40775","fullItemName":"Management","slug":"management","subChapters":[{"id":"35e8dbb5-da7f-5fd3-9ff3-b9926f24ed6e","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"8d378757-a1b8-5c8c-95b4-d1428557dcb3","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"10094473-f953-57de-8453-10fc5a4709a2","slug":"doxycycline","fullItemName":"Doxycycline"},{"id":"714c78fe-f533-5abf-8ab9-28bdb2658044","slug":"amoxicillin","fullItemName":"Amoxicillin"},{"id":"245cb0af-f052-5aa2-8912-6e553063438e","slug":"azithromycin","fullItemName":"Azithromycin"}]},{"id":"98b0aa55-4436-555a-bfde-05ef12f03083","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"0edcddd4-56b7-5124-b56a-14f7a38f3fd5","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"d42dec32-1352-5fb5-8d7d-c3591bae0448","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"254e7467-a025-51bb-849c-803edae01e3b","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"659f6620-1672-5b1d-bf3e-891ce69b4ff1","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"fdc13e77-5b9e-59a9-b651-15a5e1b1f333","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"ccedf4e2-7c6a-5251-abee-5f5f14e5ed39","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a2095079-fcfd-5a3f-85e9-d631c57dd891","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"d2ae2f81-2546-5ff8-8002-577ff4741f57","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"ab905368-8a93-5b25-a6f7-f22168c6f971","slug":"erythema-migrans","fullItemName":"Erythema migrans","depth":3,"htmlHeader":"<!-- begin field 5c69768b-43ce-4441-8107-f003199f7ff0 --><h3>Erythema migrans</h3><!-- end field 5c69768b-43ce-4441-8107-f003199f7ff0 -->","summary":null,"htmlStringContent":"<!-- begin item 9ef0a3ad-864f-4aa3-8619-2b964148b908 --><!-- begin field ec4fc74f-a376-45b1-b17b-c6e8cd8bee83 --><ul><li><strong>Primary (or solitary) erythema migrans </strong>has the following features:<ul><li><strong>Appearance </strong><ul><li>Round or oval in shape; pink, red, or purple in colour.</li><li>Usually flat, but a vesicle or pustule is present at the centre in 5% of people, and the border may be slightly raised.</li><li>There is often a central clearing or a target-like appearance (in 65–80% of people infected in Europe, but in only 20–35% of those infected in the US), or the lesion may be uniformly red (more common in the US).</li><li>See the <a data-hyperlink-id=\"c1795b87-4778-45bd-a817-a9130099a7d2\" href=\"https://www.nice.org.uk/guidance/ng95/resources/lyme-disease-rash-images-pdf-4792273597\">NICE resource</a> for images of erythema migrans.</li></ul></li><li><strong>Size</strong><ul><li>Usually expands over days to weeks.</li><li>Diameter is usually larger than 5 cm (median 16 cm), and can be as large as 1 metre.</li></ul></li><li><strong>Location</strong><ul><li>At the site of a tick bite. </li><li>Often on the legs, at flexor creases (knees, axillae, and groins), around the waistband, under the breasts, near to straps (which impede the forward progress of ticks), or (particularly in children) at the hairline or the upper parts of the body.</li></ul></li><li><strong>Timing</strong><ul><li>It usually becomes visible from 1–4 weeks (but can appear from 3 days to 3 months) after a tick bite and lasts for several weeks.</li></ul></li><li><strong>Associated symptoms</strong><ul><li>The rash is not usually itchy hot, or painful.</li><li>In Europe, around a third of people with erythema migrans experience flu-like symptoms, including fever, headache, tiredness, nausea, vomiting, arthralgia (joint pain), and myalgia (muscle pain). Flu-like symptoms are more common in the US.</li><li>Rarely, neurological features may also be present, but these usually occur later in the disease.</li></ul></li><li><strong>Be aware that a rash which is not erythema migrans can develop as a reaction to a tick bite, but it:</strong><ul><li>Usually develops and recedes during 48 hours from the time of the tick bite.</li><li>Is more likely than erythema migrans to be hot, itchy or painful.</li><li>May be caused by an inflammatory reaction or infection with a common skin pathogen.</li></ul></li></ul></li><li><strong>Secondary (or disseminated) erythema migrans </strong>may occur following haematogenous dissemination of infection, resulting in multiple lesions, usually smaller than 5 cm in diameter.</li><li><strong>Erythema migrans may be confused with a number of other skin conditions </strong>— see <a class=\"topic-reference internal-reference\" href=\"/topics/lyme-disease/diagnosis/differential-diagnosis-erythema-migrans/\">Differential diagnosis (erythema migrans)</a>.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/lyme-disease/references/\">Wormser et al, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/lyme-disease/references/\">Dubrey et al, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/lyme-disease/references/\">NICE, 2018a</a>]</p><!-- end field ec4fc74f-a376-45b1-b17b-c6e8cd8bee83 --><!-- end item 9ef0a3ad-864f-4aa3-8619-2b964148b908 -->","subChapters":[]},{"id":"d5d380db-542c-5b7d-a564-24bdc9f3440c","slug":"basis-for-recommendation-3af","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 857104ca-4754-4a23-92ce-65007e500ae6 --><h3>Basis for recommendation</h3><!-- end field 857104ca-4754-4a23-92ce-65007e500ae6 -->","summary":null,"htmlStringContent":"<!-- begin item 3afe23d0-b33d-4cf9-a250-2e55579a7b19 --><!-- begin field 1ad349b3-2fad-4fd3-9062-5af35242050c --><p>These recommendations are based on the National Institute for Health and Care Excellence (NICE) guideline <em>Lyme disease</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lyme-disease/references/\">NICE, 2018a</a>], the Public Health England (PHE) guideline <em>Suggested referral pathway for patients with symptoms related to Lyme disease </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/lyme-disease/references/\">PHE, 2014</a>] and expert opinion in a narrative review <em>Lyme disease </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/lyme-disease/references/\">Shapiro, 2014</a>]. </p><h4>Erythema migrans</h4><ul><li>Up to a third of people with Lyme disease do not have an erythema rash, or any rash. Therefore, the absence of a rash or any recollection of a tick bite does not exclude the diagnosis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lyme-disease/references/\">PHE, 2014</a>]. </li><li>Although reputed to have a bull's-eye appearance, approximately two thirds of single erythema migrans lesions are either uniformly erythematous or have enhanced central erythema without clearing around it [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lyme-disease/references/\">Shapiro, 2014</a>]. </li><li>Most people with erythema migrans (about 80%) have a single lesion, but the bacteria can disseminate hematogenously to other sites in the skin and to extra-cutaneous sites [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lyme-disease/references/\">Shapiro, 2014</a>]. </li></ul><!-- end field 1ad349b3-2fad-4fd3-9062-5af35242050c --><!-- end item 3afe23d0-b33d-4cf9-a250-2e55579a7b19 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}